Uncategorized
Alimera reports 342% total net revenue increase in 2014
Alimera Sciences reported total net revenue of $8.4 million in 2014, a 342% increase from approximately $1.9 million in 2013, according to a press release.The company began to recognize revenue in the second quarter of 2013, after the commercial launch of Iluvien (fluocinolone acetonide intravitreal implant) in Germany and the United Kingdom.